Detalhe da pesquisa
1.
Gene fusions during the early evolution of mesothelioma correlate with impaired DNA repair and Hippo pathways.
Genes Chromosomes Cancer
; 63(1): e23189, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37421230
2.
Abemaciclib in patients with p16ink4A-deficient mesothelioma (MiST2): a single-arm, open-label, phase 2 trial.
Lancet Oncol
; 23(3): 374-381, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35157829
3.
Nivolumab versus placebo in patients with relapsed malignant mesothelioma (CONFIRM): a multicentre, double-blind, randomised, phase 3 trial.
Lancet Oncol
; 22(11): 1530-1540, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34656227
4.
BAP1 loss induces mitotic defects in mesothelioma cells through BRCA1-dependent and independent mechanisms.
Oncogene
; 42(8): 572-585, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36550359
5.
Evaluating niraparib versus active symptom control in patients with previously treated mesothelioma (NERO): a study protocol for a multicentre, randomised, two-arm, open-label phase II trial in UK secondary care centres.
BMJ Open
; 13(11): e073120, 2023 11 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37993149
6.
Active symptom control with or without oral vinorelbine in patients with relapsed malignant pleural mesothelioma (VIM): A randomised, phase 2 trial.
EClinicalMedicine
; 48: 101432, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35706488
7.
Clonal architecture in mesothelioma is prognostic and shapes the tumour microenvironment.
Nat Commun
; 12(1): 1751, 2021 03 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-33741915
8.
Author Correction: Clonal architecture in mesothelioma is prognostic and shapes the tumour microenvironment.
Nat Commun
; 12(1): 3569, 2021 Jun 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34099722